APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antifungal Drugs for Skin

Compare research editions
View pricing & licenses

Selected research

Industry Research

Antifungal Drugs for Skin Industry Research Report 2026

27 December 2025148 pages

Choose your research edition.

Industry ResearchAntifungal Drugs for Skin Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Antifungal Drugs for Skin Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Antifungal Drugs for Skin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antifungal Drugs for Skin Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Antifungal Drugs for Skin Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Antifungal Drugs for Skin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Antifungal Drugs for Skin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Antifungal Drugs for Skin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Antifungal Drugs for Skin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Antifungal Drugs for Skin include Aden Healthcare, AdvaCare Pharma, Amar Healthcare, AS lifesciences, Dr. Reddy's Laboratories, Pfizer, Shree Ganesh Remedies, Solisom Healthcare and Wellona Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Antifungal Drugs for Skin market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Antifungal Drugs for Skin Market by Company

Aden Healthcare

AdvaCare Pharma

Amar Healthcare

AS lifesciences

Dr. Reddy's Laboratories

Pfizer

Shree Ganesh Remedies

Solisom Healthcare

Wellona Pharma

Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.

Harbin Labton Pharmaceutical Co., Ltd.

Harbin Pharmaceutical Group Bioengineering Co., Ltd.

Hubei Hengan Fulin Pharmaceutical Co., Ltd.

Jiangsu Chenpai Pharmaceutical Group Co., Ltd.

Livzon Group Livzon Pharmaceutical Factory

Lunan Beite Pharmaceutical Co., Ltd.

Nanjing Chengong Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.

Shandong Chenxin Fodu Pharmaceutical Co., Ltd.

Shandong Fangming Pharmaceutical Group Co., Ltd.

Shanghai Baolong Pharmaceutical Co., Ltd.

Teyi Pharmaceutical Group Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Yunnan Longrun Pharmaceutical Co., Ltd.

Zhejiang East Asia Pharmaceutical Co., Ltd.

Antifungal Drugs for Skin Segment by Type

Amorolfine

Butenafine

Ciprofloxacin

Clotrimazole

Miconazole

Terbinafine

Ketoconazole

Econazole

Other

Antifungal Drugs for Skin Segment by Application

Hospital

Clinic

Other

Antifungal Drugs for Skin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antifungal Drugs for Skin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antifungal Drugs for Skin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antifungal Drugs for Skin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Antifungal Drugs for Skin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Antifungal Drugs for Skin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Antifungal Drugs for Skin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antifungal Drugs for Skin Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Antifungal Drugs for Skin Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Antifungal Drugs for Skin Sales Market Share by Manufacturers (2021-2026) Table 8. Global Antifungal Drugs for Skin Revenue of Manufacturers (2021-2026) Table 9. Global Antifungal Drugs for Skin Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Antifungal Drugs for Skin Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Antifungal Drugs for Skin Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Antifungal Drugs for Skin, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Antifungal Drugs for Skin, Product Type & Application Table 14. Global Antifungal Drugs for Skin Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Antifungal Drugs for Skin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Aden Healthcare Company Information Table 19. Aden Healthcare Business Overview Table 20. Aden Healthcare Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Aden Healthcare Antifungal Drugs for Skin Product Portfolio Table 22. Aden Healthcare Recent Developments Table 23. AdvaCare Pharma Company Information Table 24. AdvaCare Pharma Business Overview Table 25. AdvaCare Pharma Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. AdvaCare Pharma Antifungal Drugs for Skin Product Portfolio Table 27. AdvaCare Pharma Recent Developments Table 28. Amar Healthcare Company Information Table 29. Amar Healthcare Business Overview Table 30. Amar Healthcare Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Amar Healthcare Antifungal Drugs for Skin Product Portfolio Table 32. Amar Healthcare Recent Developments Table 33. AS lifesciences Company Information Table 34. AS lifesciences Business Overview Table 35. AS lifesciences Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. AS lifesciences Antifungal Drugs for Skin Product Portfolio Table 37. AS lifesciences Recent Developments Table 38. Dr. Reddy's Laboratories Company Information Table 39. Dr. Reddy's Laboratories Business Overview Table 40. Dr. Reddy's Laboratories Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Dr. Reddy's Laboratories Antifungal Drugs for Skin Product Portfolio Table 42. Dr. Reddy's Laboratories Recent Developments Table 43. Pfizer Company Information Table 44. Pfizer Business Overview Table 45. Pfizer Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Pfizer Antifungal Drugs for Skin Product Portfolio Table 47. Pfizer Recent Developments Table 48. Shree Ganesh Remedies Company Information Table 49. Shree Ganesh Remedies Business Overview Table 50. Shree Ganesh Remedies Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Shree Ganesh Remedies Antifungal Drugs for Skin Product Portfolio Table 52. Shree Ganesh Remedies Recent Developments Table 53. Solisom Healthcare Company Information Table 54. Solisom Healthcare Business Overview Table 55. Solisom Healthcare Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Solisom Healthcare Antifungal Drugs for Skin Product Portfolio Table 57. Solisom Healthcare Recent Developments Table 58. Wellona Pharma Company Information Table 59. Wellona Pharma Business Overview Table 60. Wellona Pharma Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Wellona Pharma Antifungal Drugs for Skin Product Portfolio Table 62. Wellona Pharma Recent Developments Table 63. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Company Information Table 64. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Business Overview Table 65. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 67. Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Recent Developments Table 68. Harbin Labton Pharmaceutical Co., Ltd. Company Information Table 69. Harbin Labton Pharmaceutical Co., Ltd. Business Overview Table 70. Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 72. Harbin Labton Pharmaceutical Co., Ltd. Recent Developments Table 73. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Company Information Table 74. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Business Overview Table 75. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 77. Harbin Pharmaceutical Group Bioengineering Co., Ltd. Recent Developments Table 78. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Company Information Table 79. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Business Overview Table 80. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 82. Hubei Hengan Fulin Pharmaceutical Co., Ltd. Recent Developments Table 83. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Company Information Table 84. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Business Overview Table 85. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 87. Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Recent Developments Table 88. Livzon Group Livzon Pharmaceutical Factory Company Information Table 89. Livzon Group Livzon Pharmaceutical Factory Business Overview Table 90. Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Product Portfolio Table 92. Livzon Group Livzon Pharmaceutical Factory Recent Developments Table 93. Lunan Beite Pharmaceutical Co., Ltd. Company Information Table 94. Lunan Beite Pharmaceutical Co., Ltd. Business Overview Table 95. Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 97. Lunan Beite Pharmaceutical Co., Ltd. Recent Developments Table 98. Nanjing Chengong Pharmaceutical Co., Ltd. Company Information Table 99. Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview Table 100. Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 102. Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments Table 103. Qilu Pharmaceutical Co., Ltd. Company Information Table 104. Qilu Pharmaceutical Co., Ltd. Business Overview Table 105. Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 107. Qilu Pharmaceutical Co., Ltd. Recent Developments Table 108. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information Table 109. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview Table 110. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 112. Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Developments Table 113. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information Table 114. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview Table 115. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 117. Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Developments Table 118. Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information Table 119. Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview Table 120. Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 122. Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Developments Table 123. Shanghai Baolong Pharmaceutical Co., Ltd. Company Information Table 124. Shanghai Baolong Pharmaceutical Co., Ltd. Business Overview Table 125. Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 127. Shanghai Baolong Pharmaceutical Co., Ltd. Recent Developments Table 128. Teyi Pharmaceutical Group Co., Ltd. Company Information Table 129. Teyi Pharmaceutical Group Co., Ltd. Business Overview Table 130. Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 132. Teyi Pharmaceutical Group Co., Ltd. Recent Developments Table 133. Southwest Pharmaceutical Co., Ltd. Company Information Table 134. Southwest Pharmaceutical Co., Ltd. Business Overview Table 135. Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 137. Southwest Pharmaceutical Co., Ltd. Recent Developments Table 138. Yunnan Longrun Pharmaceutical Co., Ltd. Company Information Table 139. Yunnan Longrun Pharmaceutical Co., Ltd. Business Overview Table 140. Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 142. Yunnan Longrun Pharmaceutical Co., Ltd. Recent Developments Table 143. Zhejiang East Asia Pharmaceutical Co., Ltd. Company Information Table 144. Zhejiang East Asia Pharmaceutical Co., Ltd. Business Overview Table 145. Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio Table 147. Zhejiang East Asia Pharmaceutical Co., Ltd. Recent Developments Table 148. Global Antifungal Drugs for Skin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 149. Global Antifungal Drugs for Skin Sales by Region (2021-2026) & (K Units) Table 150. Global Antifungal Drugs for Skin Sales Market Share by Region (2021-2026) Table 151. Global Antifungal Drugs for Skin Sales by Region (2027-2032) & (K Units) Table 152. Global Antifungal Drugs for Skin Sales Market Share by Region (2027-2032) Table 153. Global Antifungal Drugs for Skin Revenue by Region (2021-2026) & (US$ Million) Table 154. Global Antifungal Drugs for Skin Revenue Market Share by Region (2021-2026) Table 155. Global Antifungal Drugs for Skin Revenue by Region (2027-2032) & (US$ Million) Table 156. Global Antifungal Drugs for Skin Revenue Market Share by Region (2027-2032) Table 157. North America Antifungal Drugs for Skin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. North America Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 159. North America Antifungal Drugs for Skin Sales by Country (2027-2032) & (K Units) Table 160. North America Antifungal Drugs for Skin Revenue by Country (2021-2026) & (US$ Million) Table 161. North America Antifungal Drugs for Skin Revenue by Country (2027-2032) & (US$ Million) Table 162. Europe Antifungal Drugs for Skin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Europe Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 164. Europe Antifungal Drugs for Skin Sales by Country (2027-2032) & (K Units) Table 165. Europe Antifungal Drugs for Skin Revenue by Country (2021-2026) & (US$ Million) Table 166. Europe Antifungal Drugs for Skin Revenue by Country (2027-2032) & (US$ Million) Table 167. Asia Pacific Antifungal Drugs for Skin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Asia Pacific Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 169. Asia Pacific Antifungal Drugs for Skin Sales by Country (2027-2032) & (K Units) Table 170. Asia Pacific Antifungal Drugs for Skin Revenue by Country (2021-2026) & (US$ Million) Table 171. Asia Pacific Antifungal Drugs for Skin Revenue by Country (2027-2032) & (US$ Million) Table 172. South America Antifungal Drugs for Skin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 173. South America Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 174. South America Antifungal Drugs for Skin Sales by Country (2027-2032) & (K Units) Table 175. South America Antifungal Drugs for Skin Revenue by Country (2021-2026) & (US$ Million) Table 176. South America Antifungal Drugs for Skin Revenue by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Antifungal Drugs for Skin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 178. Middle East and Africa Antifungal Drugs for Skin Sales by Country (2021-2026) & (K Units) Table 179. Middle East and Africa Antifungal Drugs for Skin Sales by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Antifungal Drugs for Skin Revenue by Country (2021-2026) & (US$ Million) Table 181. Middle East and Africa Antifungal Drugs for Skin Revenue by Country (2027-2032) & (US$ Million) Table 182. Global Antifungal Drugs for Skin Sales by Type (2021-2026) & (K Units) Table 183. Global Antifungal Drugs for Skin Sales by Type (2027-2032) & (K Units) Table 184. Global Antifungal Drugs for Skin Sales Market Share by Type (2021-2026) Table 185. Global Antifungal Drugs for Skin Sales Market Share by Type (2027-2032) Table 186. Global Antifungal Drugs for Skin Revenue by Type (2021-2026) & (US$ Million) Table 187. Global Antifungal Drugs for Skin Revenue by Type (2027-2032) & (US$ Million) Table 188. Global Antifungal Drugs for Skin Revenue Market Share by Type (2021-2026) Table 189. Global Antifungal Drugs for Skin Revenue Market Share by Type (2027-2032) Table 190. Global Antifungal Drugs for Skin Price by Type (2021-2026) & (US$/Unit) Table 191. Global Antifungal Drugs for Skin Price by Type (2027-2032) & (US$/Unit) Table 192. Global Antifungal Drugs for Skin Sales by Application (2021-2026) & (K Units) Table 193. Global Antifungal Drugs for Skin Sales by Application (2027-2032) & (K Units) Table 194. Global Antifungal Drugs for Skin Sales Market Share by Application (2021-2026) Table 195. Global Antifungal Drugs for Skin Sales Market Share by Application (2027-2032) Table 196. Global Antifungal Drugs for Skin Revenue by Application (2021-2026) & (US$ Million) Table 197. Global Antifungal Drugs for Skin Revenue by Application (2027-2032) & (US$ Million) Table 198. Global Antifungal Drugs for Skin Revenue Market Share by Application (2021-2026) Table 199. Global Antifungal Drugs for Skin Revenue Market Share by Application (2027-2032) Table 200. Global Antifungal Drugs for Skin Price by Application (2021-2026) & (US$/Unit) Table 201. Global Antifungal Drugs for Skin Price by Application (2027-2032) & (US$/Unit) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. Antifungal Drugs for Skin Distributors List Table 205. Antifungal Drugs for Skin Customers List Table 206. Antifungal Drugs for Skin Industry Trends Table 207. Antifungal Drugs for Skin Industry Drivers Table 208. Antifungal Drugs for Skin Industry Restraints Table 209. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Antifungal Drugs for Skin Product Image Figure 5. Global Antifungal Drugs for Skin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Antifungal Drugs for Skin Market Size (2021-2032) & (US$ Million) Figure 7. Global Antifungal Drugs for Skin Sales (2021-2032) & (K Units) Figure 8. Global Antifungal Drugs for Skin Average Price (US$/Unit) & (2021-2032) Figure 9. Amorolfine Product Image Figure 10. Butenafine Product Image Figure 11. Ciprofloxacin Product Image Figure 12. Clotrimazole Product Image Figure 13. Miconazole Product Image Figure 14. Terbinafine Product Image Figure 15. Ketoconazole Product Image Figure 16. Econazole Product Image Figure 17. Other Product Image Figure 18. Hospital Product Image Figure 19. Clinic Product Image Figure 20. Other Product Image Figure 21. Global Antifungal Drugs for Skin Revenue Share by Manufacturers in 2025 Figure 22. Global Manufacturers of Antifungal Drugs for Skin, Manufacturing Sites & Headquarters Figure 23. Global Top 5 and 10 Antifungal Drugs for Skin Players Market Share by Revenue in 2025 Figure 24. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Antifungal Drugs for Skin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 26. Global Antifungal Drugs for Skin Sales by Region in 2025 Figure 27. Global Antifungal Drugs for Skin Revenue by Region in 2025 Figure 28. North America Antifungal Drugs for Skin Market Size by Country in 2025 Figure 29. North America Antifungal Drugs for Skin Sales Market Share by Country (2021-2032) Figure 30. North America Antifungal Drugs for Skin Revenue Market Share by Country (2021-2032) Figure 31. United States Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Canada Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Mexico Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Europe Antifungal Drugs for Skin Market Size by Country in 2025 Figure 35. Europe Antifungal Drugs for Skin Sales Market Share by Country (2021-2032) Figure 36. Europe Antifungal Drugs for Skin Revenue Market Share by Country (2021-2032) Figure 37. Germany Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. France Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. U.K. Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Italy Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Russia Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Spain Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Netherlands Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Switzerland Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Sweden Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Poland Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Asia Pacific Antifungal Drugs for Skin Market Size by Country in 2025 Figure 48. Asia Pacific Antifungal Drugs for Skin Sales Market Share by Country (2021-2032) Figure 49. Asia Pacific Antifungal Drugs for Skin Revenue Market Share by Country (2021-2032) Figure 50. China Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Japan Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South Korea Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. India Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Australia Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Taiwan Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Southeast Asia Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Southeast Asia Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. South America Antifungal Drugs for Skin Market Size by Country in 2025 Figure 59. South America Antifungal Drugs for Skin Sales Market Share by Country (2021-2032) Figure 60. South America Antifungal Drugs for Skin Revenue Market Share by Country (2021-2032) Figure 61. Brazil Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Argentina Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Chile Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Middle East and Africa Antifungal Drugs for Skin Market Size by Country in 2025 Figure 65. Middle East and Africa Antifungal Drugs for Skin Sales Market Share by Country (2021-2032) Figure 66. Middle East and Africa Antifungal Drugs for Skin Revenue Market Share by Country (2021-2032) Figure 67. Egypt Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. South Africa Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Israel Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Türkiye Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. GCC Countries Antifungal Drugs for Skin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 72. Global Antifungal Drugs for Skin Sales Market Share by Type (2021-2032) Figure 73. Global Antifungal Drugs for Skin Revenue Market Share by Type (2021-2032) Figure 74. Global Antifungal Drugs for Skin Price (US$/Unit) by Type (2021-2032) Figure 75. Global Antifungal Drugs for Skin Sales Market Share by Application (2021-2032) Figure 76. Global Antifungal Drugs for Skin Revenue Market Share by Application (2021-2032) Figure 77. Global Antifungal Drugs for Skin Price (US$/Unit) by Application (2021-2032) Figure 78. Antifungal Drugs for Skin Value Chain Figure 79. Antifungal Drugs for Skin Production Mode & Process Figure 80. Direct Comparison with Distribution Share Figure 81. Distributors Profiles Figure 82. Antifungal Drugs for Skin Industry Opportunities and Challenges

Scope & coverage.

Types
  • Amorolfine
  • Butenafine
  • Ciprofloxacin
  • Clotrimazole
  • Miconazole
  • Terbinafine
  • Ketoconazole
  • Econazole
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Aden Healthcare
  • AdvaCare Pharma
  • Amar Healthcare
  • AS lifesciences
  • Dr. Reddy's Laboratories
  • Pfizer
  • Shree Ganesh Remedies
  • Solisom Healthcare
  • Wellona Pharma
  • Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
  • Harbin Labton Pharmaceutical Co., Ltd.
  • Harbin Pharmaceutical Group Bioengineering Co., Ltd.
  • Hubei Hengan Fulin Pharmaceutical Co., Ltd.
  • Jiangsu Chenpai Pharmaceutical Group Co., Ltd.
  • Livzon Group Livzon Pharmaceutical Factory
  • Lunan Beite Pharmaceutical Co., Ltd.
  • Nanjing Chengong Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  • Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  • Shandong Fangming Pharmaceutical Group Co., Ltd.
  • Shanghai Baolong Pharmaceutical Co., Ltd.
  • Teyi Pharmaceutical Group Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Yunnan Longrun Pharmaceutical Co., Ltd.
  • Zhejiang East Asia Pharmaceutical Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Antifungal Drugs for Skin Market Size (2021-2032)
  4. 2.2.2 Global Antifungal Drugs for Skin Sales (2021-2032)
  5. 2.2.3 Global Antifungal Drugs for Skin Market Average Price (2021-2032)
  6. 2.3 Antifungal Drugs for Skin by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Amorolfine
  9. 2.3.3 Butenafine
  10. 2.3.4 Ciprofloxacin
  11. 2.3.5 Clotrimazole
  12. 2.3.6 Miconazole
  13. 2.3.7 Terbinafine
  14. 2.3.8 Ketoconazole
  15. 2.3.9 Econazole
  16. 2.3.10 Other
  17. 2.4 Antifungal Drugs for Skin by Application
  18. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  19. 2.4.2 Hospital
  20. 2.4.3 Clinic
  21. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Antifungal Drugs for Skin Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Antifungal Drugs for Skin Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Antifungal Drugs for Skin Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Antifungal Drugs for Skin Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Antifungal Drugs for Skin Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Antifungal Drugs for Skin, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Antifungal Drugs for Skin, Product Type & Application
  8. 3.8 Global Manufacturers of Antifungal Drugs for Skin, Established Date
  9. 3.9 Global Antifungal Drugs for Skin Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Aden Healthcare
  2. 4.1.1 Aden Healthcare Company Information
  3. 4.1.2 Aden Healthcare Business Overview
  4. 4.1.3 Aden Healthcare Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Aden Healthcare Antifungal Drugs for Skin Product Portfolio
  6. 4.1.5 Aden Healthcare Recent Developments
  7. 4.2 AdvaCare Pharma
  8. 4.2.1 AdvaCare Pharma Company Information
  9. 4.2.2 AdvaCare Pharma Business Overview
  10. 4.2.3 AdvaCare Pharma Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 AdvaCare Pharma Antifungal Drugs for Skin Product Portfolio
  12. 4.2.5 AdvaCare Pharma Recent Developments
  13. 4.3 Amar Healthcare
  14. 4.3.1 Amar Healthcare Company Information
  15. 4.3.2 Amar Healthcare Business Overview
  16. 4.3.3 Amar Healthcare Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Amar Healthcare Antifungal Drugs for Skin Product Portfolio
  18. 4.3.5 Amar Healthcare Recent Developments
  19. 4.4 AS lifesciences
  20. 4.4.1 AS lifesciences Company Information
  21. 4.4.2 AS lifesciences Business Overview
  22. 4.4.3 AS lifesciences Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 AS lifesciences Antifungal Drugs for Skin Product Portfolio
  24. 4.4.5 AS lifesciences Recent Developments
  25. 4.5 Dr. Reddy's Laboratories
  26. 4.5.1 Dr. Reddy's Laboratories Company Information
  27. 4.5.2 Dr. Reddy's Laboratories Business Overview
  28. 4.5.3 Dr. Reddy's Laboratories Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Dr. Reddy's Laboratories Antifungal Drugs for Skin Product Portfolio
  30. 4.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 4.6 Pfizer
  32. 4.6.1 Pfizer Company Information
  33. 4.6.2 Pfizer Business Overview
  34. 4.6.3 Pfizer Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pfizer Antifungal Drugs for Skin Product Portfolio
  36. 4.6.5 Pfizer Recent Developments
  37. 4.7 Shree Ganesh Remedies
  38. 4.7.1 Shree Ganesh Remedies Company Information
  39. 4.7.2 Shree Ganesh Remedies Business Overview
  40. 4.7.3 Shree Ganesh Remedies Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Shree Ganesh Remedies Antifungal Drugs for Skin Product Portfolio
  42. 4.7.5 Shree Ganesh Remedies Recent Developments
  43. 4.8 Solisom Healthcare
  44. 4.8.1 Solisom Healthcare Company Information
  45. 4.8.2 Solisom Healthcare Business Overview
  46. 4.8.3 Solisom Healthcare Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Solisom Healthcare Antifungal Drugs for Skin Product Portfolio
  48. 4.8.5 Solisom Healthcare Recent Developments
  49. 4.9 Wellona Pharma
  50. 4.9.1 Wellona Pharma Company Information
  51. 4.9.2 Wellona Pharma Business Overview
  52. 4.9.3 Wellona Pharma Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Wellona Pharma Antifungal Drugs for Skin Product Portfolio
  54. 4.9.5 Wellona Pharma Recent Developments
  55. 4.10 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd.
  56. 4.10.1 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Company Information
  57. 4.10.2 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Business Overview
  58. 4.10.3 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  60. 4.10.5 Guangdong Zhanjiang Jimin Pharmaceutical Co., Ltd. Recent Developments
  61. 4.11 Harbin Labton Pharmaceutical Co., Ltd.
  62. 4.11.1 Harbin Labton Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Harbin Labton Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Harbin Labton Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  66. 4.11.5 Harbin Labton Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Harbin Pharmaceutical Group Bioengineering Co., Ltd.
  68. 4.12.1 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Company Information
  69. 4.12.2 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Business Overview
  70. 4.12.3 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  72. 4.12.5 Harbin Pharmaceutical Group Bioengineering Co., Ltd. Recent Developments
  73. 4.13 Hubei Hengan Fulin Pharmaceutical Co., Ltd.
  74. 4.13.1 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  78. 4.13.5 Hubei Hengan Fulin Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Jiangsu Chenpai Pharmaceutical Group Co., Ltd.
  80. 4.14.1 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Company Information
  81. 4.14.2 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Business Overview
  82. 4.14.3 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  84. 4.14.5 Jiangsu Chenpai Pharmaceutical Group Co., Ltd. Recent Developments
  85. 4.15 Livzon Group Livzon Pharmaceutical Factory
  86. 4.15.1 Livzon Group Livzon Pharmaceutical Factory Company Information
  87. 4.15.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
  88. 4.15.3 Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Livzon Group Livzon Pharmaceutical Factory Antifungal Drugs for Skin Product Portfolio
  90. 4.15.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
  91. 4.16 Lunan Beite Pharmaceutical Co., Ltd.
  92. 4.16.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
  93. 4.16.2 Lunan Beite Pharmaceutical Co., Ltd. Business Overview
  94. 4.16.3 Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Lunan Beite Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  96. 4.16.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments
  97. 4.17 Nanjing Chengong Pharmaceutical Co., Ltd.
  98. 4.17.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
  99. 4.17.2 Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview
  100. 4.17.3 Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Nanjing Chengong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  102. 4.17.5 Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments
  103. 4.18 Qilu Pharmaceutical Co., Ltd.
  104. 4.18.1 Qilu Pharmaceutical Co., Ltd. Company Information
  105. 4.18.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  106. 4.18.3 Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Qilu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  108. 4.18.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  109. 4.19 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd.
  110. 4.19.1 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Company Information
  111. 4.19.2 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Business Overview
  112. 4.19.3 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  114. 4.19.5 Shandong Bausch and Lomb Freda Pharmaceutical Co., Ltd. Recent Developments
  115. 4.20 Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
  116. 4.20.1 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Company Information
  117. 4.20.2 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Business Overview
  118. 4.20.3 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  120. 4.20.5 Shandong Chenxin Fodu Pharmaceutical Co., Ltd. Recent Developments
  121. 4.21 Shandong Fangming Pharmaceutical Group Co., Ltd.
  122. 4.21.1 Shandong Fangming Pharmaceutical Group Co., Ltd. Company Information
  123. 4.21.2 Shandong Fangming Pharmaceutical Group Co., Ltd. Business Overview
  124. 4.21.3 Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Shandong Fangming Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  126. 4.21.5 Shandong Fangming Pharmaceutical Group Co., Ltd. Recent Developments
  127. 4.22 Shanghai Baolong Pharmaceutical Co., Ltd.
  128. 4.22.1 Shanghai Baolong Pharmaceutical Co., Ltd. Company Information
  129. 4.22.2 Shanghai Baolong Pharmaceutical Co., Ltd. Business Overview
  130. 4.22.3 Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Shanghai Baolong Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  132. 4.22.5 Shanghai Baolong Pharmaceutical Co., Ltd. Recent Developments
  133. 4.23 Teyi Pharmaceutical Group Co., Ltd.
  134. 4.23.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
  135. 4.23.2 Teyi Pharmaceutical Group Co., Ltd. Business Overview
  136. 4.23.3 Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Teyi Pharmaceutical Group Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  138. 4.23.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments
  139. 4.24 Southwest Pharmaceutical Co., Ltd.
  140. 4.24.1 Southwest Pharmaceutical Co., Ltd. Company Information
  141. 4.24.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  142. 4.24.3 Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Southwest Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  144. 4.24.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  145. 4.25 Yunnan Longrun Pharmaceutical Co., Ltd.
  146. 4.25.1 Yunnan Longrun Pharmaceutical Co., Ltd. Company Information
  147. 4.25.2 Yunnan Longrun Pharmaceutical Co., Ltd. Business Overview
  148. 4.25.3 Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Yunnan Longrun Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  150. 4.25.5 Yunnan Longrun Pharmaceutical Co., Ltd. Recent Developments
  151. 4.26 Zhejiang East Asia Pharmaceutical Co., Ltd.
  152. 4.26.1 Zhejiang East Asia Pharmaceutical Co., Ltd. Company Information
  153. 4.26.2 Zhejiang East Asia Pharmaceutical Co., Ltd. Business Overview
  154. 4.26.3 Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 Zhejiang East Asia Pharmaceutical Co., Ltd. Antifungal Drugs for Skin Product Portfolio
  156. 4.26.5 Zhejiang East Asia Pharmaceutical Co., Ltd. Recent Developments
5 Global Antifungal Drugs for Skin Market Scenario by Region
  1. 5.1 Global Antifungal Drugs for Skin Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Antifungal Drugs for Skin Sales by Region: 2021-2032
  3. 5.2.1 Global Antifungal Drugs for Skin Sales by Region: 2021-2026
  4. 5.2.2 Global Antifungal Drugs for Skin Sales by Region: 2027-2032
  5. 5.3 Global Antifungal Drugs for Skin Revenue by Region: 2021-2032
  6. 5.3.1 Global Antifungal Drugs for Skin Revenue by Region: 2021-2026
  7. 5.3.2 Global Antifungal Drugs for Skin Revenue by Region: 2027-2032
  8. 5.4 North America Antifungal Drugs for Skin Market Facts & Figures by Country
  9. 5.4.1 North America Antifungal Drugs for Skin Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Antifungal Drugs for Skin Sales by Country (2021-2032)
  11. 5.4.3 North America Antifungal Drugs for Skin Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Antifungal Drugs for Skin Market Facts & Figures by Country
  16. 5.5.1 Europe Antifungal Drugs for Skin Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Antifungal Drugs for Skin Sales by Country (2021-2032)
  18. 5.5.3 Europe Antifungal Drugs for Skin Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Antifungal Drugs for Skin Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Antifungal Drugs for Skin Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Antifungal Drugs for Skin Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Antifungal Drugs for Skin Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Antifungal Drugs for Skin Market Facts & Figures by Country
  41. 5.7.1 South America Antifungal Drugs for Skin Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Antifungal Drugs for Skin Sales by Country (2021-2032)
  43. 5.7.3 South America Antifungal Drugs for Skin Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Antifungal Drugs for Skin Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Antifungal Drugs for Skin Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Antifungal Drugs for Skin Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Antifungal Drugs for Skin Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Antifungal Drugs for Skin Sales by Type (2021-2032)
  2. 6.1.1 Global Antifungal Drugs for Skin Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Antifungal Drugs for Skin Sales Market Share by Type (2021-2032)
  4. 6.2 Global Antifungal Drugs for Skin Revenue by Type (2021-2032)
  5. 6.2.1 Global Antifungal Drugs for Skin Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Antifungal Drugs for Skin Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Antifungal Drugs for Skin Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Antifungal Drugs for Skin Sales by Application (2021-2032)
  2. 7.1.1 Global Antifungal Drugs for Skin Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Antifungal Drugs for Skin Sales Market Share by Application (2021-2032)
  4. 7.2 Global Antifungal Drugs for Skin Revenue by Application (2021-2032)
  5. 7.2.1 Global Antifungal Drugs for Skin Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Antifungal Drugs for Skin Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Antifungal Drugs for Skin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Antifungal Drugs for Skin Value Chain Analysis
  2. 8.1.1 Antifungal Drugs for Skin Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Antifungal Drugs for Skin Production Mode & Process
  5. 8.2 Antifungal Drugs for Skin Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Antifungal Drugs for Skin Distributors
  8. 8.2.3 Antifungal Drugs for Skin Customers
9 Global Antifungal Drugs for Skin Analyzing Market Dynamics
  1. 9.1 Antifungal Drugs for Skin Industry Trends
  2. 9.2 Antifungal Drugs for Skin Industry Drivers
  3. 9.3 Antifungal Drugs for Skin Industry Opportunities and Challenges
  4. 9.4 Antifungal Drugs for Skin Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst